Skip to content

Cold/Hot Pack

by Ningbo Tianbo First Aid Product Co., Ltd.

Ref Rule 1

Cold/Hot Pack (Rule 1) is a medical device (EU MDR Class I; EMDN category cryotherapy and thermotherapy devices) made by Ningbo Tianbo First Aid Product Co., Ltd., registered in EUDAMED on 29 May 2025 (Basic UDI-DI 697471270TBBD01JF), active as of 7 Nov 2026.

Active European Union

CE MDR

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None, self-declared

Class I: no certifier involved

Trust

Unverified

Source EUDAMED, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number697471270TBBD01JF Basic UDI-DI 06974712701514UDI-DIDate29 May 2025RegisteredStatusActive

Official records

Certificates

0 certificates · EUDAMED

No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDR Active

Specification

EUDAMED

Device name
Cold/Hot Pack
Model / reference
Rule 1
Primary DI / UDI-DI
06974712701514
Basic UDI-DI
697471270TBBD01JF
Direct marketing DI
06974712701514
EMDN code
M9001 Cryotherapy and thermotherapy devices
Device class
Class I
System or procedure pack
System which is a device in itself
EU registration type
Standard device
EU market of registration
Sweden

Manufacturer details

EUDAMED SRN
CN-MF-000016721
Authorised representative
Prolinx GmbH DE-AR-000005129

Similar devices in this category

Other devices filed under CRYOTHERAPY AND THERMOTHERAPY DEVICES.

Other devices from Ningbo Tianbo First Aid Product Co., Ltd.

See all devices from Ningbo Tianbo First Aid Product Co., Ltd. →

Properties

Other properties (14, all answered No)